ISSN:

Journal Home

Journal Guideline

Expert Opinion on Orphan Drugs Q3 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Orphan Drugs is a journal indexed in SJR in Health Policy and Pharmacology (medical) with an H index of 27. It has a price of 1800 €. It has an SJR impact factor of 0,199 and it has a best quartile of Q3. It has an SJR impact factor of 0,199.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (medical) (Q3) Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3) Health Policy (Q4)

Price

1800 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,199

SJR Impact factor

27

H Index

3

Total Docs (Last Year)

85

Total Docs (3 years)

174

Total Refs

66

Total Cites (3 years)

82

Citable Docs (3 years)

0.86

Cites/Doc (2 years)

58.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Ambulatory Care Management Q3
Journal of Health Management Q3
Journal of Research in Health Sciences Q3
Australian Journal of Primary Health Q3
American Journal of Medical Quality Q3

Compare this journals